Cutler Group LP Pacific Biosciences Of California, Inc. Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$8.23 - $13.93 $86,415 - $146,265	10,500 Added 8750.0%	10,620 $88,000
Q2 2023 Jul 18, 2023	BUY	$9.97 - $14.05 $109 - $154	11 Added 10.09%	120 $1,000
Q1 2023 May 01, 2023	SELL	$7.94 - $12.02 $117,527 - $177,920	-14,802 Reduced 99.27%	109 $1,000
Q4 2022 Feb 07, 2023	BUY	$5.67 - $11.2 $12,893 - $25,468	2,274 Added 17.99%	14,911 $121,000
Q3 2022 Oct 25, 2022	SELL	$3.93 - $8.57 $1,135 - $2,476	-289 Reduced 2.24%	12,637 $73,000
Q2 2022 Aug 04, 2022	BUY	$4.02 - $10.43 $5,595 - $14,518	1,392 Added 12.07%	12,926 $57,000
Q1 2022 Apr 14, 2022	BUY	$8.43 - $20.9 $12,813 - $31,767	1,520 Added 15.18%	11,534 $104,000
Q4 2021 Jan 18, 2022	BUY	$19.26 - $30.08 $154,349 - $241,061	8,014 Added 400.7%	10,014 $204,000
Q2 2021 Jul 19, 2021	SELL	$22.3 - $36.02 $814,039 - $1.31 Million	-36,504 Reduced 94.81%	2,000 $69,000
Q1 2021 Apr 26, 2021	BUY	$26.38 - $51.15 $1.01 Million - $1.96 Million	38,404 Added 38404.0%	38,504 $1.28 Million
Q4 2020 Jan 21, 2021	BUY	$10.5 - $28.5 $1,050 - $2,850	100 New	100 $2,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.